<code id='5802F2D011'></code><style id='5802F2D011'></style>
    • <acronym id='5802F2D011'></acronym>
      <center id='5802F2D011'><center id='5802F2D011'><tfoot id='5802F2D011'></tfoot></center><abbr id='5802F2D011'><dir id='5802F2D011'><tfoot id='5802F2D011'></tfoot><noframes id='5802F2D011'>

    • <optgroup id='5802F2D011'><strike id='5802F2D011'><sup id='5802F2D011'></sup></strike><code id='5802F2D011'></code></optgroup>
        1. <b id='5802F2D011'><label id='5802F2D011'><select id='5802F2D011'><dt id='5802F2D011'><span id='5802F2D011'></span></dt></select></label></b><u id='5802F2D011'></u>
          <i id='5802F2D011'><strike id='5802F2D011'><tt id='5802F2D011'><pre id='5802F2D011'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:Wikipedia    Page View:412
          Cigna logo
          Julia Rendleman/Getty Images for Eventive Marketing

          Health insurer Cigna is paying more than $172 million to settle allegations that it committed fraud by knowingly submitting inaccurate diagnoses of its Medicare Advantage members, the company and Department of Justice announced Saturday.

          The settlement stems from a wide-ranging government investigation into the coding practices of Medicare Advantage insurers, as well as a specific whistleblower lawsuit against Cigna that the DOJ joined last year.

          advertisement

          That lawsuit alleged Cigna’s home visit program “regularly generated false and invalid diagnosis codes for certain serious, complex conditions that cannot be reliably diagnosed in a home setting and without extensive diagnostic testing or imaging,” the DOJ said.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          In early work, researchers turn to CRISPR to treat Alzheimer's
          In early work, researchers turn to CRISPR to treat Alzheimer's

          AdobeWhenthegenome-editingtoolCRISPRisthoughtofasapotentialmedicine,thetargetsthatfirstcometomindare

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          At Orexo, a ‘turning point’ for everything but digital health

          AdobeMosteverythingislookingupforOrexo,thecompanyreportedonitssecondquarterearningscallonTuesday.Tha